Publications by authors named "V H Brown"

Desktop three-dimensional (3D) printers are used in businesses, schools, and colleges, and are generally of an unenclosed design which may give rise to injuries or inhalation exposure to emissions of small particles (<1 µm) and volatile organic compounds (VOCs). The aim of this work was to explore the health risks related to the use of desktop 3D printers in workplaces in the United Kingdom. A digital survey on the use of desktop 3D printers was completed voluntarily and anonymously between February and June 2023, receiving 146 responses.

View Article and Find Full Text PDF

Using a prion amplification assay, we identified prions in tissues from wild pigs (Sus scrofa) living in areas of the United States with variable chronic wasting disease (CWD) epidemiology. Our findings indicate that scavenging swine could play a role in disseminating CWD and could therefore influence its epidemiology, geographic distribution, and interspecies spread.

View Article and Find Full Text PDF
Article Synopsis
  • During the COVID-19 pandemic, Melbourne, Australia, faced extended lockdowns, prompting a study on children's health in 2022 compared to pre-pandemic data from 2019.
  • The study found that primary school children in 2022 had higher rates of overweight and obesity, lower physical activity levels, and poorer diet quality compared to 2019.
  • Results indicate a decline in health-related quality of life among children post-lockdown, highlighting the need for ongoing monitoring and interventions to address rising childhood obesity.
View Article and Find Full Text PDF

In June 2024, a group of 12 experts in the respiratory syncytial virus (RSV) field representing a cross-section of healthcare provider types who treat and care for pregnant individuals and infants, assembled to discuss the implementation of a broad infant prophylaxis program with nirsevimab in Ontario. To gain insight on potential best practices founded on the experiences of other jurisdictions, the meeting comprised a review of the 2023/2024 RSV season programs in Spain, France, and the United States that implemented nirsevimab prophylaxis. The impact of nirsevimab in reducing severe RSV disease among infants during the first RSV season was assessed including the implications on hospital resources and healthcare system costs.

View Article and Find Full Text PDF